絞り込み

16544

広告

Genomic / mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.

著者 Li M , Liu F , Zhang F , Zhou W , Jiang X , Yang Y , Qu K , Wang Y , Ma Q , Wang T , Bai L , Wang Z , Song X , Zhu Y , Yuan R , Gao Y , Liu Y , Jin Y , Li H , Xiang S , Ye Y , Zhang Y , Jiang L , Hu Y , Hao Y , Lu W , Chen S , Gu J , Zhou J , Gong W , Zha
Gut.2018 Jun 28 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (27view , 0users)

Full Text Sources

Medical

Miscellaneous

Molecular Biology Databases

MalaCards for gallbladder cancer

Patients with gallbladder carcinoma (GBC) lack effective treatment methods largely due to the inadequacy of both molecular characterisation and potential therapeutic targets. We previously uncovered a spectrum of genomic alterations and identified recurrent mutations in the ErbB pathway in GBC. Here, we aimed to study recurrent mutations of genes and pathways in a larger cohort of patients with GBC and investigate the potential mechanisms and clinical significance of these mutations.
PMID: 29954840 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード